Valneva's Ixchiq has been suspended by France's HAS (national public health agency) for the use in persons aged >65 y.o pending further investigation, after three cases of SAEs (all in patients >80, with one death) have been reported in the French pharmacovigilence database — these cases have
Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities Saint Herblain (France), April 26, 2025 – (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its recommendation for use of Valneva’s single-dose chikungunya vaccine IXCHIQ® for the prevention of disease caused by the chikungunya virus (CHIKV) following reports of serious adverse events (SAEs) in elderly people with comorbidities during the ongoing vaccination campaign in ...
Valneva fait un point sur la recommandation d’utilisation de son vaccin contre le chikungunya par les autorités françaises Saint Herblain (France), le 26 avril 2025 – (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l’autorité publique de santé en France, la Haute Autorité de Santé (HAS), a mis à jour sa recommandation concernant l'utilisation du vaccin à dose unique de Valneva, IXCHIQ®, pour la prévention de la maladie causée par le virus du chikungunya (CHIKV) suite à une notification d'effets indésirables graves chez des personnes â...
Eramet: 2.7bn€ in economic contribution and 260,000 beneficiaries of social initiatives in the countries where it operates by 2024 PRESS RELEASE Paris, April 24, 2025, 8:00 am Eramet: 2.7bn€ in economic contribution and 260,000 beneficiaries of social initiatives in the countries where it operates by 2024 Eramet confirms its commitment to developing the local economies of its host countries by generating 2.7bn€ in direct economic contribution in 2024. The Group's investments in social initiatives in favor of local communities doubled, reaching 16.2 M€ for more than 260,000 beneficiar...
Eramet : 2,7 Mds€ de retombées économiques et 260 000 bénéficiaires d’actions sociétales dans ses pays d’implantation en 2024 COMMUNIQUE DE PRESSE Paris, le 24 avril 2025, 8h00 Eramet : 2,7 Mds€ de retombées économiques et 260 000 bénéficiaires d’actions sociétales dans ses pays d’implantation en 2024 Eramet confirme son engagement en faveur du développement des économies locales de ses pays hôtes en générant 2,7 Mds€ de retombées économiques directes en 2024. Les investissements du Groupe dans des actions sociétales en faveur des communautés locales ont doublé, atteignant 16,2 M€ pour p...
Eramet: Stability in Q1 2025 turnover Paris, 24 April 2025, 7:30 a.m. PRESS RELEASE Eramet: Stability in Q1 2025 turnover Adjusted turnover1 of €742m, stable versus Q1 2024, reflecting a negative volume/mix effect (-5%), offset by positive price (+3%) and currency (+3%) effectsIncrease in nickel ore production in Indonesia (+3% vs. Q1 2024); temporary destocking of the plants at the Weda Bay industrial park at the start of the year, weighing on sales (-11%)Operational and logistics difficulties encountered since end-2024 at the port of Owendo in Gabon, combined with a social movement in ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.